UGI: Q2 Earnings Insights

UGI (NYSE:UGI) reported its Q2 earnings results on Wednesday, May 3, 2023 at 04:45 PM. Here’s what investors…

UGI (NYSE:UGI) reported its Q2 earnings results on Wednesday, May 3, 2023 at 04:45 PM.

Here’s what investors need to know about the announcement.

Earnings

UGI missed estimated earnings by 5.62%, reporting an EPS of $1.68 versus an estimate of $1.78.

Revenue was down $360.00 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.19 which was followed by a 5.29% increase in the share price the next day.

Here’s a look at UGI’s past performance:

Quarter Q1 2023 Q4 2022 Q3 2022 Q2 2022
EPS Estimate 0.95 -0.07 0.13 1.85
EPS Actual 1.14 0 0.06 1.91
Revenue Estimate 2.81B 1.93B 1.90B 2.85B
Revenue Actual 2.76B 1.93B 2.03B 3.47B

To track all earnings releases for UGI visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Braxia Scientific Q2 2023 Financial Results: Health Clinic Ketamine Treatments Increases 34.5% YoY

Braxia Scientific Corp., (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders, announced the filing of its financial statements and management discussion and analysis for the

BRAXF